
No. of Pages: 107 | Report Code: TIPRE00026147 | Category: Life Sciences
No. of Pages: 107 | Report Code: TIPRE00026147 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Metabolomics Services Market – By Service Type
1.3.2 Europe Metabolomics Services Market – By Application
1.3.3 Europe Metabolomics Services Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5.1 Market Drivers
5.1.1 Uprising Incidences of Cancer
5.1.2 Rise in Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Growth Opportunities in Several Countries
5.4 Future Trends
5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
6.1 Europe Metabolomics Services Market Revenue Forecast and Analysis
7.1 Overview
7.2 Europe Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8.1 Overview
8.2 Europe Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9.1.1 Europe: Metabolomics Services Market, by Country, 2021 & 2028(%)
9.1.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3.1 Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.2 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3.1 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3.1 UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.4 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3.1 Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3.1 Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3.1 Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
10.1 Overview
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Proteomics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 RTI International
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Afekta Technologies Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fred Hutchinson Cancer Research Center
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Metabolon, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 biocrates life sciences ag
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 metaSysX
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MS-Omics
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. Europe Metabolomics Services Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 5. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 20. organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Metabolomics Services Market
Figure 1. Europe Metabolomics Services Market Segmentation
Figure 2. Europe Metabolomics Services Market, By Country
Figure 3. Europe Metabolomics Services Market Overview
Figure 4. Targeted Metabolomics Service Segment Held Largest Share of Type Segment in Europe Metabolomics Services Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Impact Analysis of Drivers and Restraints Pertaining to Metabolomics Services Market
Figure 9. Europe Metabolomics Services Market– By Revenue Forecast and Analysis – 2019- 2028
Figure 10. Europe Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 11. Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 14. Europe Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 15. Europe Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 16. Europe Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 17. Europe Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 18. Europe Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. Europe Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Europe Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Europe: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Europe: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets